NIH-funded research NIH-funded research

Understanding how certain immune cells protect against respiratory viruses

Official title: Mechanisms of CD8 TRM-mediated protection against respiratory virus transmission

Funded at Emory University · NIH-11125010 · Data updated 2026-11-12

This study is looking at how special immune cells in the lungs can help fight off respiratory viruses, like different versions of the coronavirus, and it aims to find out how these cells can stop the virus from spreading and protect you from getting sick.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startJuly 26, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$640,735
NIH project number1R56AI177703-01A1
Project IDNIH-11125010 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been exposed to respiratory viruses or are at high risk for such infections.

Less likely to help

Patients who are not at risk for respiratory infections or those with pre-existing conditions that severely compromise their immune response may not benefit from this research.

What this research studies

This research investigates the role of tissue-resident memory T cells (TRM) in the respiratory tract and their ability to recognize and respond to respiratory viruses, including variants of the 2019 novel coronavirus. By using a murine model, the study aims to uncover how these immune cells can limit viral transmission and protect against infection. The researchers will explore the mechanisms by which TRM can identify and eliminate infected cells in the respiratory epithelium, potentially leading to new insights into immune responses against respiratory viruses.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing the transmission of respiratory viruses, including COVID-19.

How similar studies have gone: Previous research has shown that tissue-resident memory T cells can provide protection against viral infections, suggesting that this approach has potential for success.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Kohlmeier, Jacob E — Emory University
  • Study coordinator: Kohlmeier, Jacob E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.